Table 3.
Plasma miR-105-5p expression vs. internal control in all groups.
Groups | Number | miR-105-5p (mean ± SEM) | P-value | P-value |
---|---|---|---|---|
HC | 273 | 0.065 ± 0.011 | Ref | |
IPD | 319 | 0.163 ± 0.018 | P < 0.001 | Ref |
NDC | 305 | 0.047 ± 0.007 | NS | P < 0.001 |
epilepsy | 69 | 0.031 ± 0.009 | NS | P < 0.001 |
cerebrovascular disease | 57 | 0.028 ± 0.008 | NS | P < 0.001 |
AD | 49 | 0.035 ± 0.013 | NS | P < 0.001 |
Parkinsonian syndrome | 47 | 0.053 ± 0.012 | NS | P < 0.001 |
ET | 22 | 0.069 ± 0.051 | NS | P < 0.05 |
myasthenia gravis | 14 | 0.020 ± 0.014 | NS | P < 0.001 |
motor neuron disease | 14 | 0.031 ± 0.011 | NS | P < 0.001 |
peripheral neuropathy | 11 | 0.074 ± 0.039 | NS | NS |
Ref, Reference; NS, not significant; HC, healthy controls; IPD, idiopathic Parkinson’s disease; NDC, neurological disease control; AD, Alzheimer’s disease; ET, essential tremor. This list displays the disease that numbers in group ≥10. Wilcoxon Rank-Sum (Mann–Whiney Test).